Introduction
Traumatic brain injury is an injury caused by external force hitting the brain. Traumatic brain injury can damage the cranial nerves, leading to loss of movement or cognitive function of the patient. The central nervous system is difficult to regenerate and restore after being damaged, Common treatments include physical therapy, hyperbaric oxygen therapy, cranial magnetic stimulation, and cranial direct current stimulation. There is currently no effective therapy for nerve regeneration in traumatic brain injury. Patients with traumatic brain injury often have brain lesions after a period of time and will cause brain degenerative diseases in the future. Therefore, the early use of drugs that promote brain nerve regeneration after brain injury is a therapeutic solution. Isorhoifolin is a currently known compound, and the research on this compound as a drug for treatment is rare. Although it is seen that the composition containing this compound is used for the treatment of venous problems or hemorrhoids, but It is not intended for use in the treatment of nerve-related diseases. Therefore, further research in the present invention found that Isorhoifolin and its derivatives can effectively promote nerve repair and regeneration, and can penetrate the blood-brain barrier, which can be used to develop potential drugs for the treatment of traumatic brain injury.
Features / strengths
Isorhoifolin and the derivative thereof can be used for promoting the regeneration of damaged brain neurons and retinal nerves.
Specification in detail
Under development
Seek of partners for business cooperation
